Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, pp.2095-2128, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00827612
Deaths: preliminary data for, Natl Vital Stat Rep, vol.59, pp.1-52, 2008. ,
Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis, Lancet Respir Med, vol.2, pp.54-62, 2014. ,
Measuring the global burden of disease, N Engl J Med, vol.369, pp.448-457, 2013. ,
50-year trends in smoking-related mortality in the United States, N Engl J Med, vol.368, pp.351-364, 2013. ,
The clinical and economic burden of chronic obstructive pulmonary disease in the USA, Clinicoecon Outcomes Res, vol.5, pp.235-245, 2013. ,
ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, Eur Respir J, vol.23, pp.932-946, 2004. ,
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am J Respir Crit Care Med, vol.187, pp.347-365, 2013. ,
Guideline Development Group. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance, BMJ, vol.340, p.3134, 2010. ,
Estimation of cigarette smoking-attributable morbidity in the United States, JAMA Intern Med, vol.174, pp.1922-1928, 2014. ,
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, vol.380, pp.37-43, 2012. ,
Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement, Int J Chron Obstruct Pulmon Dis, vol.7, pp.697-709, 2012. ,
Acute respiratory illness as a trigger for detecting chronic bronchitis in adults at risk of COPD: a primary care survey, Prim Care Respir J, vol.19, pp.371-377, 2010. ,
Validation and comparison of reference equations for the 6-min walk distance test, Eur Respir J, vol.31, pp.571-578, 2008. ,
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status, Am J Respir Crit Care Med, vol.167, pp.544-549, 2003. ,
Quantitative assessment of the airway wall using computed tomography and optical coherence tomography, Proc Am Thorac Soc, vol.6, pp.439-443, 2009. ,
Thin-section CT in obstructive pulmonary disease: discriminatory value, Radiology, vol.223, pp.812-819, 2002. ,
New and current clinical imaging techniques to study chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.180, pp.588-597, 2009. ,
COPDGene CT Workshop Group. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation, COPD, vol.9, pp.151-159, 2012. ,
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression, Nat Med, vol.18, pp.1711-1715, 2012. ,
Accuracy of low-dose computed tomography (CT) for detecting and characterizing the most common CT-patterns of pulmonary disease, Eur J Radiol, vol.82, pp.142-150, 2013. ,
Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers, Am J Respir Crit Care Med, vol.188, pp.1083-1090, 2013. ,
Using pulmonary imaging to move COPD beyond FEV1, Am J Respir Crit Care Med, vol.190, pp.135-144, 2014. ,
Lung cancer in patients with chronic obstructive pulmonary disease -incidence and predicting factors, Am J Respir Crit Care Med, vol.184, pp.913-919, 2011. ,
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers, Eur Respir J, vol.20, pp.1117-1122, 2002. ,
Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes, Thorax, vol.63, pp.1040-1045, 2008. ,
COPDGene Investigators. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction, Thorax, vol.69, pp.409-414, 2014. ,
High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden -a challenge for public health, BMC Public Health, vol.13, pp.670-678, 2013. ,
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD, Thorax, vol.63, pp.768-774, 2008. ,
Preventive Services Task Force. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, vol.148, pp.529-534, 2008. ,
The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Chronic obstructive pulmonary disease stage and health-related quality of life, Ann Intern Med, vol.127, pp.1072-1079, 1997. ,
Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD, Chest, vol.115, pp.635-641, 1999. ,
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, pp.1297-1303, 2000. ,
Acute exacerbation of COPD: factors associated with poor treatment outcome, Chest, vol.117, pp.662-671, 2000. ,
Prognosis in chronic obstructive pulmonary disease, Am Rev Respir Dis, vol.133, pp.14-20, 1986. ,
Population impact of different definitions of airway obstruction, Eur Respir J, vol.22, pp.268-273, 2003. ,
American Thoracic Society Committee on Dyspnea. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea, Am J Respir Crit Care Med, vol.185, pp.435-452, 2012. ,
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.1791-1797, 1998. ,
Prognostic value of nutritional status in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.1856-1861, 1999. ,
Patient-reported dyspnea in COPD reliability and association with stage of disease, Chest, vol.136, pp.1473-1479, 2009. ,
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD, Chest, vol.121, pp.1434-1440, 2002. ,
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study, Thorax, vol.61, pp.772-778, 2006. ,
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease, N Engl J Med, vol.350, pp.1005-1012, 2004. ,
The modified BODE index: validation with mortality in COPD, Eur Respir J, vol.32, pp.1269-1274, 2008. ,
Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients, Respir Med, vol.103, pp.692-699, 2009. ,
Multicomponent indices to predict survival in COPD: the COCOMICS study, Eur Respir J, vol.42, pp.323-332, 2013. ,
ECLIPSE Investigators. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.185, pp.1065-1072, 2012. ,
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index, Lancet, vol.374, pp.704-711, 2009. ,
Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index, Am J Respir Crit Care Med, vol.180, pp.1189-1195, 2009. ,
Working Group on COPD, Spanish Society of Internal Medicine. Shortand medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index, Chest, vol.145, pp.972-980, 2014. ,
Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population, Am J Respir Crit Care Med, vol.186, pp.975-981, 2012. ,
Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification, Chest, vol.143, pp.694-702, 2013. ,
Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization, Am J Respir Crit Care Med, vol.188, pp.51-59, 2013. ,
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.186, pp.155-161, 2012. ,
Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.188, pp.1396-1406, 2013. ,
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease, Thorax, vol.57, pp.847-852, 2002. ,
ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD, N Engl J Med, vol.365, pp.1184-1192, 2011. ,
Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort, Respir Res, vol.11, pp.122-136, 2010. ,
The human phenome project, Nat Genet, vol.34, pp.15-21, 2003. ,
Chronic obstructive pulmonary disease phenotypes: the future of COPD, Am J Respir Crit Care Med, vol.182, pp.598-604, 2010. ,
Ageing and multimorbidity, Eur Respir J, vol.44, p.557, 2014. ,
Network medicine, multimorbidity and the lung in the elderly, Eur Respir J, vol.44, pp.775-788, 2014. ,
Ageing and the epidemiology of multimorbidity, Eur Respir J, vol.44, pp.1055-1068, 2014. ,
The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD, Chest, vol.141, pp.851-857, 2012. ,
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur Respir J, vol.32, pp.962-969, 2008. ,
Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the Pittsburgh lung screening study, J Thorac Oncol, vol.6, pp.1200-1205, 2011. ,
TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease, N Engl J Med, vol.356, pp.775-789, 2007. ,
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.187, pp.728-735, 2013. ,
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease, Eur J Clin Invest, vol.43, pp.510-521, 2013. ,
Increased risk of myocardial infarction and stroke following exacerbation of COPD, Chest, vol.137, pp.1091-1097, 2010. ,
COPDGene Investigators. Prediction of acute respiratory disease in current and former smokers with and without COPD, Chest, vol.146, pp.941-950, 2014. ,
CanCOLD Collaborative Research Group. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study, Thorax, vol.69, pp.709-717, 2014. ,
Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome, Am J Respir Crit Care Med, vol.182, pp.325-331, 2010. ,
Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.156, pp.341-357, 1997. ,
A hypothesis for the initiation of COPD, Eur Respir J, vol.34, pp.310-315, 2009. ,
Infection in the pathogenesis and course of chronic obstructive pulmonary disease, N Engl J Med, vol.359, pp.2355-2365, 2008. ,
The lung microbiome in moderate and severe chronic obstructive pulmonary disease, PLoS ONE, vol.7, p.47305, 2012. ,
Immunologic aspects of chronic obstructive pulmonary disease, N Engl J Med, vol.360, pp.2445-2454, 2009. ,
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema, Respir Res, vol.7, p.53, 2006. ,
Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, vol.186, pp.306-313, 2012. ,
Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development, Curr Drug Metab, vol.9, pp.661-667, 2008. ,
Cigarette smoke and CFTR: implications in the pathogenesis of COPD, Am J Physiol Lung Cell Mol Physiol, vol.305, pp.530-541, 2013. ,
CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.157, pp.822-826, 1998. ,
Inflammation and repair processes in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.160, pp.12-16, 1999. ,
Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.159, pp.1605-1611, 1999. ,
Pathophysiology of chronic obstructive pulmonary disease, Eur Respir Monogr, vol.3, pp.107-126, 1998. ,
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1, Am J Respir Crit Care Med, vol.155, pp.852-857, 1997. ,
The changes in airways structure associated with reduced forced expiratory volume in one second, Eur Respir J, vol.2, pp.834-839, 1989. ,
Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.164, pp.770-777, 2001. ,
Global effects of smoking, of quitting, and of taxing tobacco, N Engl J Med, vol.370, pp.60-68, 2014. ,
Smoking and lung function of Lung Health Study participants after 11 years, Am J Respir Crit Care Med, vol.166, pp.675-679, 2002. ,
Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial, BMJ, vol.336, pp.598-600, 2008. ,
Smokers with airway obstruction are more likely to quit smoking, Thorax, vol.61, pp.869-873, 2006. ,
The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD, Scand J Prim Health Care, vol.24, pp.133-139, 2006. ,
Efficacy of confronting smokers with airflow limitation for smoking cessation, Eur Respir J, vol.33, pp.754-762, 2009. ,
Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD, Chest, vol.119, pp.1365-1370, 2001. ,
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, Lancet, vol.357, pp.1571-1575, 2001. ,
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial, Chest, vol.139, pp.591-599, 2011. ,
Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support, Chest, vol.130, pp.334-342, 2006. ,
The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review, Respir Med, vol.98, pp.805-815, 2004. ,
Depression in the patient with COPD, Int J Chron Obstruct Pulmon Dis, vol.1, pp.61-64, 2006. ,
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial, Circulation, vol.121, pp.221-229, 2010. ,
Updated US smoking cessation guideline advises counseling, combining therapies, JAMA, vol.299, p.2736, 2008. ,
Systematic review and meta-analysis of combination therapy for smoking cessation, J Am Pharm Assoc, vol.48, pp.659-665, 2003. ,
Triple-combination pharmacotherapy for medically ill smokers: a randomized trial, Ann Intern Med, vol.150, pp.447-454, 2009. ,
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies, Arch Gen Psychiatry, vol.66, pp.1253-1262, 2009. ,
Effect of varying levels of disease management on smoking cessation: a randomized trial, Ann Intern Med, vol.150, pp.437-446, 2009. ,
Update. Clinical Practice Guidelines. Rockville, US Department of Health and Human Services, 2008. ,
Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients, Psychopharmacology (Berl), vol.119, pp.193-204, 1995. ,
Electronic nicotine delivery systems: a research agenda, Tob Control, vol.20, pp.243-248, 2011. ,
Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy, Addiction, vol.106, pp.2017-2028, 2011. ,
Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey, Drug Alcohol Rev, vol.32, pp.133-140, 2013. ,
Electronic cigarettes: a short review, Respiration, vol.86, pp.433-438, 2013. ,
Electronic cigarettes: a position statement of the forum of international respiratory societies, Am J Respir Crit Care Med, vol.190, pp.611-618, 2014. ,
The effect of smoking cessation and modification on lung function, Am Rev Respir Dis, vol.114, pp.115-122, 1976. ,
Harm reduction-a treatment approach for resistant smokers with tobacco-related symptoms, Respiration, vol.69, pp.452-455, 2002. ,
Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers, Eur Respir J, vol.3, pp.752-759, 1990. ,
Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study, Eur Respir J, vol.25, pp.1011-1017, 2005. ,
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review, Nicotine Tob Res, vol.8, pp.739-749, 2006. ,
Use of electronic health records to support smoking cessation, Cochrane Database Syst Rev, vol.12, p.8743, 2011. ,
Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review, Arch Intern Med, vol.167, pp.221-228, 2007. ,
UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease, N Engl J Med, vol.359, pp.1543-1554, 2008. ,
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study, Respir Res, vol.10, p.59, 2009. ,
UPLIFT® Study Investigators. Tiotropium might improve survival in subjects with COPD at high risk of mortality, Respir Res, vol.15, p.64, 2014. ,
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study, Am J Respir Crit Care Med, vol.178, pp.332-338, 2008. ,
UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial, Lancet, vol.374, pp.1171-1178, 2009. ,
Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality, PLoS ONE, vol.7, p.51048, 2012. ,
Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision, S Afr Med J, vol.94, pp.559-575, 2004. ,
The role of bronchodilator treatment in the prevention of exacerbations of COPD, Eur Respir J, vol.40, pp.1545-1554, 2012. ,
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy, Am J Respir Crit Care Med, vol.189, pp.1503-1508, 2014. ,
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.9, p.9157, 2012. ,
Effect of ADRB2 polymorphism on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial, Lancet Respir Med, vol.2, pp.44-53, 2014. ,
INVIGORATE investigators. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study, Lancet Respir Med, vol.1, pp.524-533, 2013. ,
Investigating New Standards for Prophylaxis in Reduction of Exacerbations (INSPIRE) Investigators. Reported pneumonia in patients with COPD: findings from the INSPIRE study, Chest, vol.139, pp.505-512, 2011. ,
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results, Eur Respir J, vol.34, pp.641-647, 2009. ,
INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide, Am J Respir Crit Care Med, vol.177, pp.19-26, 2008. ,
Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.146, pp.545-555, 2007. ,
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study, Lancet Respir Med, vol.1, pp.199-209, 2013. ,
The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting ?-agonist therapy in COPD, Chest, vol.141, pp.81-86, 2012. ,
Korean Academy of Tuberculosis and Respiratory Diseases study group; Korea Chronic Obstructive Pulmonary Disease study group. Comparison of tiotropium plus fluticasone propionate/ salmeterol with tiotropium in COPD: a randomized controlled study, Respir Med, vol.106, pp.382-389, 2012. ,
Withdrawal of inhaled glucocorticoids and exacerbations of COPD, N Engl J Med, vol.371, pp.1285-1294, 2014. ,
The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study, Thorax, vol.66, pp.425-429, 2011. ,
Development and first validation of the COPD Assessment Test, Eur Respir J, vol.34, pp.648-654, 2009. ,
Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation, Chest, vol.142, pp.134-140, 2012. ,
Adherence to inhaled therapy, mortality and hospital admission in COPD, Thorax, vol.64, pp.939-943, 2009. ,
Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs, Respir Med, vol.105, pp.435-441, 2011. ,
Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study, Trials, vol.12, p.40, 2011. ,
Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control, Respir Med, vol.105, pp.930-938, 2011. ,
The ADMIT series -Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD, Prim Care Respir J, vol.19, pp.10-20, 2010. ,
European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies, Eur Respir J, vol.37, pp.1308-1331, 2011. ,
Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity-a common inflammatory phenotype?, Respir Res, vol.7, p.70, 2006. ,
New anti-inflammatory targets for chronic obstructive pulmonary disease, Nat Rev Drug Discov, vol.12, pp.543-559, 2013. ,
New insights into the immunology of chronic obstructive pulmonary disease, Lancet, vol.378, pp.1015-1026, 2011. ,
COPD Investigators. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.175, pp.926-934, 2007. ,
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomized, double-blind, placebo-controlled, phase 2a study, Lancet Respir Med, vol.2, pp.891-901, 2014. ,
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.5, p.2309, 2011. ,
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD, Eur Respir J, vol.30, pp.472-478, 2007. ,
Losmapimod Study Investigators. An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease, J Clin Pharmacol, vol.52, pp.416-424, 2012. ,
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial, Lancet Respir Med, vol.2, pp.63-72, 2014. ,
Glucocorticoid resistance in inflammatory diseases, Lancet, vol.373, pp.1905-1917, 2009. ,
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis, Eur Respir J, vol.44, pp.789-791, 2014. ,
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial, Am J Respir Crit Care Med, vol.186, pp.48-55, 2012. ,
Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma, Ann Am Thorac Soc, vol.11, pp.1011-1017, 2014. ,
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial, Lancet, vol.380, pp.651-659, 2012. ,
Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.178, pp.139-148, 2008. ,
Macrolide effects on the prevention of COPD exacerbations, Eur Respir J, vol.40, pp.485-494, 2012. ,
COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD, N Engl J Med, vol.365, pp.689-698, 2011. ,
Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations, Am J Respir Crit Care Med, vol.178, pp.1139-1147, 2008. ,
Azithromycin and the risk of cardiovascular death, N Engl J Med, vol.366, pp.1881-1890, 2012. ,
Oral erythromycin and the risk of sudden death from cardiac causes, N Engl J Med, vol.351, pp.1089-1096, 2004. ,
Use of azithromycin and death from cardiovascular causes, N Engl J Med, vol.368, pp.1704-1712, 2013. ,
PULSE Study group. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial, Respir Res, vol.11, p.10, 2010. ,
Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management, Expert Opin Drug Deliv, vol.8, pp.1205-1220, 2011. ,
Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence, Postgrad Med J, vol.85, pp.414-421, 2009. ,
An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease, Respirology, vol.17, pp.493-498, 2012. ,
Statins and outcome after hospitalization for COPD exacerbation: a prospective study, Pulm Pharmacol Ther, vol.24, pp.625-631, 2011. ,
Statins in COPD: a systematic review, Chest, vol.136, pp.734-743, 2009. ,
Associations between statins and COPD: a systematic review, BMC Pulm Med, vol.9, p.32, 2009. ,
Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension, Clin Sci, vol.116, pp.497-505, 2009. ,
COPD Clinical Research Network; Canadian Institutes of Health Research. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD, N Engl J Med, vol.370, pp.2201-2210, 2014. ,
UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation, Thorax, vol.61, pp.837-842, 2006. ,
Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease, Arch Intern Med, vol.170, pp.880-887, 2010. ,
Systemic manifestations of COPD, Chest, vol.139, pp.165-173, 2011. ,
statement: key concepts and advances in pulmonary rehabilitation, Am J Respir Crit Care Med, vol.188, pp.13-64, 2013. ,
Home-based pulmonary rehabilitation in chronic obstructive pulmonary disease patients, Curr Opin Pulm Med, vol.16, pp.134-143, 2010. ,
Chronic Obstructive Pulmonary Disease Axis of Respiratory Health Network, Fonds de recherche en santé du Québec. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial, Ann Intern Med, vol.149, pp.869-878, 2008. ,
Short-and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial, Thorax, vol.65, pp.7-13, 2010. ,
Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial, J Am Med Dir Assoc, vol.11, pp.179-187, 2010. ,
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.10, p.5305, 2011. ,
Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD, Chest, vol.127, pp.809-817, 2005. ,
, Report of the Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema, Lancet, vol.1, pp.681-686, 1981.
, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial, Ann Intern Med, vol.93, pp.391-398, 1980.
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia, Thorax, vol.52, pp.674-679, 1997. ,
A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients, Eur Respir J, vol.14, pp.1002-1008, 1999. ,
Continuous oxygen therapy in chronic airway obstruction. Observations on possible oxygen toxicity and survival, Ann Intern Med, vol.75, pp.361-367, 1971. ,
Nonmedical hazards of long-term oxygen therapy, Respir Care, vol.28, pp.906-912, 1983. ,
Review of burn injuries secondary to home oxygen, J Burn Care Res, vol.33, pp.212-217, 2012. ,
Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease, N Engl J Med, vol.333, pp.817-822, 1995. ,
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease, Lancet, vol.341, pp.1555-1557, 1993. ,
Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure, Am J Respir Crit Care Med, vol.151, pp.1799-1806, 1995. ,
Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial, Lancet, vol.355, pp.1931-1935, 2000. ,
Non-invasive ventilation in acute respiratory failure, Lancet, vol.374, pp.250-259, 2009. ,
Noninvasive positive pressure ventilation in subjects with stable COPD: a randomized trial, Int J Chron Obstruct Pulmon Dis, vol.8, pp.581-589, 2013. ,
Bénéfices de la ventilation non invasive à domicile au décours d'une insuffisance respiratoire aiguë hypercapnique chez les patients BPCO. Étude contrôlée randomisée multicentrique. Étude Non Invasive Ventilation in Obstructive Lung Disease (Nivold) [A multi-centre randomised controlled trial of domiciliary non-invasive ventilation vs long-term oxygen therapy in survivors of acute hypercapnic respiratory failure due to COPD. Non-invasive ventilation ,
, Rev Mal Respir, vol.29, pp.1141-1148, 2012.
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients, Eur Respir J, vol.20, pp.529-538, 2002. ,
Nocturnal non-invasive ventilation in COPD patients with prolonged hypercapnia after ventilatory support for acute respiratory failure: a randomised, controlled, parallel-group study, Thorax, vol.69, pp.826-834, 2014. ,
Nocturnal noninvasive positive pressure ventilation in stable COPD: a systematic review and individual patient data meta-analysis, Respir Med, vol.108, pp.329-337, 2014. ,
Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial, Lancet Respir Med, vol.2, pp.698-705, 2014. ,
Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease, Thorax, vol.58, pp.634-638, 2003. ,
National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema, N Engl J Med, vol.348, pp.2059-2073, 2003. ,
National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema, N Engl J Med, vol.348, pp.2092-2102, 2003. ,
VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema, N Engl J Med, vol.363, pp.1233-1244, 2010. ,
International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012, J Heart Lung Transplant, vol.31, pp.1073-1086, 2012. ,
Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.177, pp.1156-1163, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00282520
Survival impact of lung transplantation for COPD, Eur Respir J, vol.36, pp.74-80, 2010. ,
BODE index and quality of life in advanced chronic obstructive pulmonary disease before and after lung transplantation, J Heart Lung Transplant, vol.30, pp.1334-1341, 2011. ,
Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, vol.25, pp.745-755, 2006. ,
Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data, Lancet, vol.371, pp.744-751, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00282487
Assessing the benefit of accepting a single lung offer now compared with waiting for a subsequent double lung offer, Transplantation, vol.91, pp.921-926, 2011. ,
The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease, Am J Respir Crit Care Med, vol.184, pp.1282-1288, 2011. ,
The pathophysiology of cachexia in chronic obstructive pulmonary disease, Curr Opin Support Palliat Care, vol.3, pp.282-287, 2009. ,
Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease, Respir Med, vol.94, pp.859-867, 2000. ,
Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function, Eur J Clin Nutr, vol.52, pp.396-401, 1998. ,
Relation between physical capacity, nutritional status and systemic inflammation in COPD, Clin Respir J, vol.5, pp.136-142, 2011. ,
Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis, Am J Clin Nutr, vol.95, pp.1385-1395, 2012. ,
Nutritional support for individuals with COPD: a meta-analysis, Chest, vol.117, pp.672-678, 2000. ,
ERS Research Seminar Faculty. Physical activity, nutritional status and systemic inflammation in COPD, Eur Respir J, vol.40, pp.522-529, 2012. ,
Diet and vitamin D as risk factors for lung impairment and COPD, Transl Res, vol.162, pp.219-236, 2013. ,
Supplemental vitamin D and physical performance in COPD: a pilot randomized trial, Int J Chron Obstruct Pulmon Dis, vol.8, pp.97-104, 2013. ,
Chronic Obstructive Pulmonary Disease axis of the Respiratory Network Fonds de la Recherche en Santé du Québec. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention, Arch Intern Med, vol.163, pp.585-591, 2003. ,
CHRONIC project. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients, Eur Respir J, vol.21, pp.58-67, 2003. ,
Effects of an integrated care intervention on risk factors of COPD readmission, Respir Med, vol.101, pp.1462-1469, 2007. ,
members of the CHRONIC Project. Integrated care prevents hospitalisations for exacerbations in COPD patients, Eur Respir J, vol.28, pp.123-130, 2006. ,
Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial, Am J Respir Crit Care Med, vol.182, pp.890-896, 2010. ,
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial, Ann Intern Med, vol.156, pp.673-683, 2012. ,
Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence, BMJ, vol.329, p.315, 2004. ,
Integrated care: a new model for COPD management?, Eur Respir J, vol.28, pp.4-6, 2006. ,
Telemedicine-assisted home support for patients with advanced chronic obstructive pulmonary disease: preliminary results after nine-month follow-up, J Telemed Telecare, vol.11, pp.86-88, 2005. ,
Tele-assistance in chronic respiratory failure patients: a randomised clinical trial, Eur Respir J, vol.33, pp.411-418, 2009. ,
Effects of home telemonitoring to support improved care for chronic obstructive pulmonary diseases, Telemed J E Health, vol.17, pp.95-103, 2011. ,
Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial, BMJ, vol.347, p.6070, 2013. ,
Barriers and facilitators to end-of-life care communication for patients with COPD, Chest, vol.127, pp.2188-2196, 2005. ,
Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer, Arch Intern Med, vol.166, pp.326-331, 2006. ,
Patient-physician communication about end-of-life care for patients with severe COPD, Eur Respir J, vol.24, pp.200-205, 2004. ,
A randomized trial to improve communication about end-of-life care among patients with COPD, Chest, vol.141, pp.726-735, 2012. ,
Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT, J Am Geriatr Soc, vol.48, pp.146-153, 2000. ,
Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey, Br J Gen Pract, vol.61, pp.362-370, 2011. ,
Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure, J Palliat Med, vol.14, pp.735-743, 2011. ,
Barriers to advance care planning in chronic obstructive pulmonary disease, Palliat Med, vol.23, pp.642-648, 2009. ,
Patient-clinician communication about end-of-life care for Dutch and US patients with COPD, Eur Respir J, vol.38, pp.268-276, 2011. ,
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) ,
, Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/ AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Echocardiography, vol.116, pp.418-499, 2007.
Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?, J Am Coll Cardiol, vol.48, pp.964-969, 2006. ,
DECREASE Study Group. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study, J Am Coll Cardiol, vol.49, pp.1763-1769, 2007. ,
Coronary-artery revascularization before elective major vascular surgery, N Engl J Med, vol.351, pp.2795-2804, 2004. ,
, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery, Thorax, vol.56, pp.89-108, 2001.
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidence-based clinical practice guidelines, Chest, vol.132, pp.161-177, 2007. ,
Preoperative considerations for patients with chronic obstructive pulmonary disease, Acta Chir Iugosl, vol.58, pp.71-75, 2011. ,
Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection, Ann Thorac Surg, vol.86, pp.240-247, 2008. ,
Ventilation-perfusion scintigraphy to predict postoperative pulmonary function in lung cancer patients undergoing pneumonectomy, AJR Am J Roentgenol, vol.187, pp.1260-1265, 2006. ,
Diffusing capacity predicts morbidity and mortality after pulmonary resection, J Thorac Cardiovasc Surg, vol.96, pp.894-900, 1988. ,
Relationship of predicted postoperative product to postpneumonectomy cardiopulmonary complications, J Chin Med Assoc, vol.66, pp.643-654, 2003. ,
Relationship of carbon monoxide pulmonary diffusing capacity to postoperative cardiopulmonary complications in patients undergoing pneumonectomy, Kaohsiung J Med Sci, vol.19, pp.437-446, 2003. ,
Exercise capacity as a predictor of postoperative complications in lung resection candidates, Am J Respir Crit Care Med, vol.151, pp.1472-1480, 1995. ,
Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection, Chest, vol.102, pp.1774-1779, 1992. ,
Preoperative assessment as a predictor of mortality and morbidity after lung resection, Am Rev Respir Dis, vol.139, pp.902-910, 1989. ,
Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality, Am J Respir Crit Care Med, vol.150, pp.947-955, 1994. ,
A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer, Ann Thorac Surg, vol.39, pp.260-265, 1985. ,
Prediction of postoperative respiratory failure in patients undergoing lung resection for lung cancer, Ann Thorac Surg, vol.46, pp.549-552, 1988. ,
Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, vol.147, pp.738-744, 2014. ,
Predictors of early morbidity after major lung resection in patients with and without airflow limitation, Ann Thorac Surg, vol.74, pp.999-1003, 2002. ,
High prevalence of respiratory symptoms during air travel in patients with COPD, Respir Med, vol.105, pp.50-56, 2011. ,
British Thoracic Society Standards of Care Committee. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations, Thorax, vol.66, pp.1-30, 2011. ,
Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel, Curr Opin Pulm Med, vol.12, pp.140-144, 2006. ,
Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease, Aviat Space Environ Med, vol.79, pp.518-524, 2008. ,
COPD and air travel: oxygen equipment and preflight titration of supplemental oxygen, Chest, vol.140, pp.84-90, 2011. ,
Guideline for the management of chronic obstructive pulmonary disease-2011 update, S Afr Med J, vol.101, pp.63-73, 2011. ,
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients, Eur Respir J, vol.24, pp.580-586, 2004. ,